Predictors and their primary studies with confirmation and replication status
Group | No | Predictors | Model mentioning predictor | Status |
Ocular features | 1 | Retinopathy level/DR grade | Lagani et al14 | C,48 R70 |
2 | Proliferative DR | Hippisley-Cox and Coupland11* | C,48 R71 | |
3 | Maculopathy | Hippisley-Cox et al11* | C,48 R71 | |
4 | Visual acuity score | Lagani et al14 | C51 | |
Sociodemographics | 5 | Age | Multiple studies11 42 57 | C,43 R55 |
6 | Race | Harris et al 11 63 (L) | E3 63 Lack of evidence | |
7 | Gender | Harris et al63 | C,62 R43 | |
8 | Social deprivation score | Hippisley-Cox and Coupland11* | C,59 R72 | |
Diabetes characteristics | 9 | Type of DM | Icelandic model73* | C74 |
10 | Age at diagnosis | UKPDS OM275* | C,76 R55 | |
11 | Duration of DM | Icelandic model73 | C,48 R70 | |
Biochemical parameters | 12 | HbA1c | UKPDS OM177 | C,51 R49 |
13 | eGFR | UKPDS OM275 Stratton et al,60 ISDR35* | C,78 R38 C,79 R55 | |
14 | Total serum cholesterol | Soedamah-Muthu et al57 UKPDS OM177 | C,39 R55 C,40 R53 | |
Physical examination | 15 | DBP | Icelandic model73* | C74 |
16 | SBP | UKPDS OM277* | C,76 R55 | |
Comorbidities | 17 | Hypertension | Harris et al63 | C39 |
18 | Dyslipidaemia | Harris et al63 | C,79 R80 | |
29 | Psychiatric illness | Lagani et al14 (L)* | Absence of evidence | |
Diabetic complications | 20 | Chronic renal disease | *Hippisley-Cox and Coupland11 | C81 |
21 | Diabetic nephropathy | Harris et al63 | C,62 R37 | |
22 | Diabetic neuropathy | Harris et al63 (L)* | Absence of evidence | |
Diabetes treatment | 23 | Statin | Harris et al63 | C,82 R80 |
24 | Insulin | Harris et al63* | C,83 R50 | |
Lifestyle | 25 | Smoking | McEwan et al61 (L) | C,43 44 Absence of evidence |
26 | BMI | McEwan et al and others14 42 61 (L)* | C,41 Absence of evidence | |
27 | Exercise/physical activity | Tanaka13 (L) | Absence of evidence | |
New from NGT | 28 | Only eye situation | NA (L) | Absence of evidence |
29 | Early worsening | NA | C,45 R84 | |
30 | Frequent DNA | NA (L) | C47 Lack of evidence | |
31 | Pregnancy | NA | C,46 R52 | |
32 | Diet | NA (L) | Absence of evidence | |
33 | Preproliferative DR | NA | C,48 R85 | |
34 | Chronic infection | NA (L) | Absence of evidence | |
35 | Comorbidities | NA (L) | Absence of evidence |
*Modelling study did not clearly identify the primary study for the predictor. Details in text.
BMI, body mass index; C, confirmation; DBP, diastolic blood pressure; DM, diabetes mellitus; DNA, did not attend; DR, diabetic retinopathy; E, exploration; eGFR, estimated glomerular filtration rate; HbA1c, glycated haemoglobin; ISDR, Individualised Screening for Diabetic Retinopathy; L, lacking evidence; NA, not applicable; R, replication; SBP, systolic blood pressure ; UKPDS, United Kingdom prospective Diabetes Study.